Patent · US Active

RNA formulations

US11786607B2 · kind B2 · utility

17Cited by

84References

22Claims

0Family size

Assignee

ModernaTX, Inc. · US

Inventors

Stephen Hoge · Brookline, US
Joseph Schariter · Waltham, US
Charles Bowerman · Waltham, US
Michael H. Smith · Goornong, AU
Yan Xia · Edison, US

Key dates

Filing date	Jun 15, 2018
Grant date	Oct 17, 2023
Priority date	—
Expiry date	Sep 9, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/88
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides improved lipid-based compositions, including lipid nanoparticle compositions, and methods of use thereof for delivering agents in vivo including nucleic acids and proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.